GlaxoSmithKline Pharmaceuticals Limited — Others, 18-06-2025: Disclosure under SEBI Takeover Regulations

Glaxo Group Limited has announced that the promoters and persons acting in concert have not created any encumbrance or pledge on their shares in GlaxoSmithKline Pharmaceuticals Limited during the financial year. As of the year-end, none of the promoter-held shares are encumbered. This confirms the promoters’ continued full control over their stake, which is relevant for shareholder confidence and stability in ownership.